Cargando…

Genital inflammation undermines the effectiveness of tenofovir gel in preventing HIV acquisition in women

Several clinical trials have demonstrated that antiretroviral (ARV) drugs, taken as pre-exposure prophylaxis (PrEP), can prevent HIV infection(1), with the magnitude of protection ranging from -49 to 86%(2–11). While these divergent outcomes are thought to be due primarily to product adherence(12),...

Descripción completa

Detalles Bibliográficos
Autores principales:	McKinnon, Lyle R., Liebenberg, Lenine J., Yende-Zuma, Nonhlanhla, Archary, Derseree, Ngcapu, Sinaye, Sivro, Aida, Nagelkerke, Nico, Lerma, Gerardo Garcia, Kashuba, Angela D., Masson, Lindi, Mansoor, Leila E., Karim, Quarraisha Abdool, Abdool Karim, Salim S., Passmore, Jo-Ann S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893390/ https://www.ncbi.nlm.nih.gov/pubmed/29480895 http://dx.doi.org/10.1038/nm.4506

Ejemplares similares

HPV infection and the genital cytokine milieu in women at high risk of HIV acquisition
por: Liebenberg, Lenine J. P., et al.
Publicado: (2019)

Topical Tenofovir Pre-exposure Prophylaxis and Mucosal HIV-Specific Fc-Mediated Antibody Activities in Women
por: Fisher, Kimone Leigh, et al.
Publicado: (2020)

Higher mucosal antibody concentrations in women with genital tract inflammation
por: Sobia, Parveen, et al.
Publicado: (2021)

Ex vivo HIV entry into blood CD4+ T cells does not predict heterosexual HIV acquisition in women
por: Joag, Vineet, et al.
Publicado: (2018)

Diminished HIV Infection of Target CD4+ T Cells in a Toll-Like Receptor 4 Stimulated in vitro Model
por: Cromarty, Ross, et al.
Publicado: (2019)

Genital—Systemic Chemokine Gradients and the Risk of HIV Acquisition in Women
por: Liebenberg, Lenine J. P., et al.
Publicado: (2017)

Pre-infection plasma cytokines and chemokines as predictors of HIV disease progression
por: Ngcobo, Samukelisiwe, et al.
Publicado: (2022)

Betamethasone induces potent immunosuppression and reduces HIV infection in a PBMC in vitro model
por: Cromarty, Ross, et al.
Publicado: (2021)

The Impact of Semen Exposure on the Immune and Microbial Environments of the Female Genital Tract
por: Jewanraj, Janine, et al.
Publicado: (2020)

Modulation of Female Genital Tract-Derived Dendritic Cell Migration and Activation in Response to Inflammatory Cytokines and Toll-Like Receptor Agonists
por: Shey, Muki S., et al.
Publicado: (2016)

Plasma Biomarkers of Risk of Tuberculosis Recurrence in HIV Co-Infected Patients From South Africa
por: Pillay, Kimesha, et al.
Publicado: (2021)

Transient association between semen exposure and biomarkers of genital inflammation in South African women at risk of HIV infection
por: Jewanraj, Janine, et al.
Publicado: (2021)

Women with Pregnancies Had Lower Adherence to 1% Tenofovir Vaginal Gel as HIV Preexposure Prophylaxis in CAPRISA 004, a Phase IIB Randomized-Controlled Trial
por: Matthews, Lynn T., et al.
Publicado: (2013)

Honing in on enteric fever
por: McKinnon, Lyle R, et al.
Publicado: (2014)

HIV prevalence among high school learners - opportunities for schools-based HIV testing programmes and sexual reproductive health services
por: Kharsany, Ayesha BM, et al.
Publicado: (2012)

Recent Semen Exposure Impacts the Cytokine Response and Bacterial Vaginosis in Women
por: Mngomezulu, Khanyisile, et al.
Publicado: (2021)

Age-Restriction of a Validated Risk Scoring Tool Better Predicts HIV Acquisition in South African Women: CAPRISA 004
por: Castor, Delivette, et al.
Publicado: (2022)

Mechanisms of sexually transmitted infection‐induced inflammation in women: implications for HIV risk
por: Mwatelah, Ruth, et al.
Publicado: (2019)

Bugs, drugs, and HIV: the role of the vaginal microbiome in HIV risk and antiretroviral efficacy for HIV prevention
por: Liebenberg, Lenine J. P., et al.
Publicado: (2017)

High incidence and persistence of hepatitis B virus infection in individuals receiving HIV care in KwaZulu-Natal, South Africa
por: Msomi, Nokukhanya, et al.
Publicado: (2020)

Pharmacogenomics of drug transporters for antiretroviral long-acting pre-exposure prophylaxis for HIV
por: Zondo, Nomusa M., et al.
Publicado: (2022)

Frequency of Hepatitis B Virus Resistance Mutations in Women Using Tenofovir Gel as Pre-Exposure Prophylaxis
por: Baxter, Cheryl, et al.
Publicado: (2019)

Semen IgM, IgG1, and IgG3 Differentially Associate With Pro-Inflammatory Cytokines in HIV-Infected Men
por: Pillay, Thevani, et al.
Publicado: (2019)

Vaginal microbial shifts are unaffected by oral pre-exposure prophylaxis in South African women
por: Mazibuko-Motau, Noluthando, et al.
Publicado: (2022)

Blood monocyte and dendritic cell profiles among people living with HIV with Mycobacterium tuberculosis co-infection
por: Rambaran, Santhuri, et al.
Publicado: (2023)

CAPRISA 018: a phase I/II clinical trial study protocol to assess the safety, acceptability, tolerability and pharmacokinetics of a sustained-release tenofovir alafenamide subdermal implant for HIV prevention in women
por: Gengiah, Tanuja Narayansamy, et al.
Publicado: (2022)

Clinical Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 Rapid Antigen Tests During the Omicron Wave in South Africa( )
por: Samsunder, Natasha, et al.
Publicado: (2022)

Temporal Changes in Vaginal Microbiota and Genital Tract Cytokines Among South African Women Treated for Bacterial Vaginosis
por: Mtshali, Andile, et al.
Publicado: (2021)

High mortality rates in men initiated on anti-retroviral treatment in KwaZulu-Natal, South Africa
por: Naidoo, Kogieleum, et al.
Publicado: (2017)

Field evaluations of four SARS-CoV-2 rapid antigen tests during SARS-CoV-2 Delta variant wave in South Africa
por: Samsunder, Natasha, et al.
Publicado: (2023)

Distinct genital tract HIV-specific antibody profiles associated with tenofovir gel
por: Archary, D, et al.
Publicado: (2016)

Trial participation disclosure and gel use behavior in the CAPRISA 004 tenofovir gel trial
por: Succop, Stacey M., et al.
Publicado: (2014)

Semen: A modulator of female genital tract inflammation and a vector for HIV‐1 transmission
por: Jewanraj, Janine, et al.
Publicado: (2021)

Randomized Cross-Sectional Study to Compare HIV-1 Specific Antibody and Cytokine Concentrations in Female Genital Secretions Obtained by Menstrual Cup and Cervicovaginal Lavage
por: Archary, Derseree, et al.
Publicado: (2015)

Metronidazole Treatment Failure and Persistent BV Lead to Increased Frequencies of Activated T- and Dendritic-Cell Subsets
por: Qulu, Wenkosi Perez, et al.
Publicado: (2023)

Assessing the safety and pharmacokinetics of the monoclonal antibodies, VRC07-523LS and PGT121 in HIV negative women in South Africa: study protocol for the CAPRISA 012A randomised controlled phase I trial
por: Mahomed, Sharana, et al.
Publicado: (2019)

Brief Report: Selection of HIV-1 Variants With Higher Transmission Potential by 1% Tenofovir Gel Microbicide
por: Ngandu, Nobubelo K., et al.
Publicado: (2017)

Implementation of Adolescent-Friendly Voluntary Medical Male Circumcision Using a School Based Recruitment Program in Rural KwaZulu-Natal, South Africa
por: Montague, Carl, et al.
Publicado: (2014)

Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial
por: Karim, Quarraisha Abdool, et al.
Publicado: (2011)

Performance of rapid antigen tests in identifying Omicron BA.4 and BA.5 infections in South Africa
por: Samsunder, Natasha, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6k58upvgv942m23qh7gphac4ms